Atlas Trials

Effect of Single Doses of 10 mg NRL001 Applied as a Suppository to the Anal Canal or Rectum

Clinical trial NCT00893607 · COMPLETED

Trial details

NCT number
NCT00893607
Sponsor
Norgine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Fecal Incontinence
Start date
2007-04-01
Primary completion
2007-08-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.